that develops in five characteristic stages. Caused mainly by herpes simplex virus type 2 (HSV-2), the disease is characterized by recurrent outbreaks in which the dormant virus will suddenly ...

HSV-2 causes genital herpes, and neurological complications include aseptic meningitis and recurrent radiculopathy. HSV-2 also causes myelitis in immunocompromised individuals. Typical features of ...

Most cases of genital herpes are due to the herpes simplex virus type 2 (HSV-2). Herpes simplex virus type 1 (HSV-1) mostly causes cold sores or fever blisters. But it can also cause genital herpes.

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ground to mRNA shots in development at Moderna and BioNTech.

GSK has announced that Part II of the Phase I/II TH HSV REC-003 trial of its therapeutic ... a marker of type 2 inflammation.

New work from Fred Hutch Cancer Center virologists shows that gene drive, which pushes a trait through a population, occurs ...

An analysis of data from the phase 2 portion of the trial showed the primary efficacy objective had not been met. A study investigating GSK’s investigational herpes simplex virus (HSV ...

The Phase 2 study was conducted in 261 healthy HSV-2 seropositive adults, 18 to 50 years of age, with a self-reported history of 4 to 9 recurrences per year. Subjects were randomized 2:1 to ...

The TH HSV REC-003 study will carry on for routine safety monitoring ... In other recent news, GSK has reported positive results from its SWIFT-1 and SWIFT-2 phase III clinical trials, demonstrating ...

Jia Zhu studies the human immune response to reactivation of human herpes simplex virus type 2, the virus responsible for genital ... behave in genital tissues during the latent and active phases of ...

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ground to mRNA shots in development at Moderna and BioNTech.